You can buy or sell AC Immune and other stocks, options, ETFs, and crypto commission-free!
AC Immune SA Common Stock, also called AC Immune, is a clinical stage biopharmaceutical company, which engages in developing therapeutic and diagnostic products. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. Read More The company was founded by Jean-Marie Lehn, Claude Nicolau, Roscoe Brady, Fred van Leuven, Ruth Greferath, Andrea Pfeifer, and Alexey V. Eleesiv on February 13, 2003 and is headquartered in Lausanne, Switzerland.
Lausanne, Basel-Landschaft (Basle Country)
52 Week High
52 Week Low
BRIEF-Ac Immune Receives Second Milestone And New Milestone To Increase The Potential Deal Value Of Lilly Morphomer™ Tau Partnership
March 23 (Reuters) - AC Immune SA: * AC IMMUNE RECEIVES SECOND MILESTONE AND NEW MILESTONE TO INCREASE THE POTENTIAL DEAL VALUE OF LILLY MORPHOMER™ TAU PARTNER
— per share
Expected Apr 13, Pre-Market